372
Participants
Start Date
October 31, 2011
Primary Completion Date
February 28, 2013
Study Completion Date
February 28, 2013
TAK-438
TAK-438 20 mg, tablets, orally, once daily for up to 6 weeks.
Placebo
Lansoprazole placebo-matching capsules, orally, once daily for up to 6 weeks.
Lansoprazole
Lansoprazole 30 mg, capsules, orally, once daily for up to 6 weeks.
Placebo
TAK-438 placebo-matching tablets, orally, once daily for up to 6 weeks.
Toyota-shi
Kamagaya-shi
Kisarazu-shi
Fukui-shi
Fukuoka
Kitakyushu-shi
Kurume-shi
Onga-gun
Tagawa-shi
Yanagawa-shi
Yukuhashi-shi
Sappori-shi
Kobe
Nishinomiya-shi
Takarazuka-shi
Hitachi-shi
Hitacinaka-shi
Marugame-shi
Takamatsu
Kagoshima
Kanoya-shi
Kawasaki-shi
Yokohama
Kumamoto
Yashiro-shi
Kyoto
Nagasaki
Sasebo-shi
Ōita
Okayama
Shimajiri-gun
Daito-shi
Fujiidera-shi
Hirakata-shi
Kishiwada-shi
Osaka
Sakai-shi
Suita-shi
Takatsuki-shi
Toyonaka-shi
Saga
Ageo-shi
Kumagaya-shi
Tokorozawa-shi
Ōtsu
Shizuoka
Ashikaga-shi
Otawara-shi
Shimotsuga-gun
Shimotsuke-shi
Tokushima
Hachioji-shi
Kodaira-shi
Kokubunji-shi
Meguro-ku
Minato-ku
Mitaka-shi
Ōta-ku
Setagaya-ku
Shinagawa-ku
Wakayama
Yamagata
Shimonoseki-shi
Kofu
Lead Sponsor
Takeda
INDUSTRY